NASDAQ Stocks In Massive Losing Stream: DIAL, DVAX, SCMR, TZYM
Houston, TX – November 19, 2012 — (Net PR News) – AnotherWinningTrade.com, the leader for breaking information and up-to-date market activities on Wall Street, locates high-growth equity opportunities. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s focus is on: DIAL, DVAX, SCMR, TZYM
Dial Global Inc. (NASDAQ: DIAL) was among the percentage losers and fell-76.68%. DIAL traded with volume of 802,168.00 shares in the last session as compared to average volume of 4,274.00 shares. The stock showed downbeat weekly, monthly and quarterly performances of -79.07%, -82.75% and -80.62%, respectively. The stock lost more than 76 percent after Dial Global Inc. (NASDAQ: DIAL) made an announcement regarding the company’s voluntarily intention to delist from the NASDAQ exchange.
Dial Global Inc. (NASDAQ: DIAL) operates as an independent, full-service network radio company in the United States. Dial Global, Inc. is headquartered in New York, New York.
How Should Investors Trade DIAL Now? Don’t Trade DIAL until you Read this Trend Analysis Report
Dynavax Technologies Corporation (NASDAQ: DVAX) On November 16, 2012, the stock, after opening at $2.30, gained the high price range in the previous trading day of $2.58 and then closed at $2.44 by scoring -47.30%. DVAX was a loser in its weekly, monthly and quarterly performances as it shed -39.15%, – 51.78%, and -35.79%, respectively. Dynavax Technologies Corporation (NASDAQ: DVAX) has updated that the company has received input and votes from the U.S FDA Vaccines and Related Biological Products Advisory Committee, so DVAX will carry on working with the FDA.
Dynavax Technologies Corporation (NASDAQ: DVAX), a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
How Should Investors React To DVAX Now? Find Out in this Trend Analysis Report
Sycamore Networks, Inc. (NASDAQ: SCMR) stock after opening at $3.31, gained the high price range in the previous trading day of $3.31 and then closed at $2.81. The 52 week range of SCMR remained $2.65 – $20.16. In the trading session of November 16, 2012, the stock plunged -21.51%. Sycamore Networks, Inc. (NASDAQ: SCMR) shares dropped as the company looks for approval for liquidation. The company reported in a filing that the utmost amount available for distribution to shareholders will be approximately $2.60 for each share on approval of a sale.
Sycamore Networks, Inc. (NASDAQ: SCMR) engages in the development and marketing of intelligent bandwidth management solutions for fixed line and mobile network operators worldwide.
Get a free report and detailed analysis on SCMR Click Here to read
Tranzyme Inc. (NASDAQ: TZYM) stock’s market capitalization was 22.08 million. TZYM fell -15.61% during the latest trading session. TZYM’s 5 days performance graph showed a bearish movement of -80.25%. Tranzyme Inc. (NASDAQ: TZYM) plunged more than 15% in the previous trade as the company’s diabetic gastro paresis drug, TZP-102, failed in a clinical trial. The company has updated on Thursday that it’s diabetic gastro paresis drug TZP-102’s one per day dose does not work.
Tranzyme Inc. (NASDAQ: TZYM) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders.
Is TZYM a solid investment at these levels? Find out EXACTLY where TZYM is headed with this TREND ANALYSIS REPORT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.